Fineline Cube

Follow:
14486 Articles
Frontera Therapeutics Advances to Phase II with FT-003 for Diabetic Macular Edema
CompanyDrug

Frontera Therapeutics Advances to Phase II with FT-003 for Diabetic Macular Edema

Johnson & Johnson's Rybrevant Combo Approved by EC for First-Line NSCLC Treatment
CompanyDrug

Johnson & Johnson’s Rybrevant Combo Approved by EC for First-Line NSCLC Treatment

BeiGene Secures Global Rights to Duality Biologics' B7H4 Targeted ADC DB1312/BG-C9074
CompanyDeals

BeiGene Secures Global Rights to Duality Biologics’ B7H4 Targeted ADC DB1312/BG-C9074

Novartis Announces Positive Results from Phase III STEER Study on SMA Treatment
CompanyDrug

Novartis Announces Positive Results from Phase III STEER Study on SMA Treatment

10th National VBP Round Results Announced: Contracts Worth Over RMB1.3 Billion
DrugMedical Device

10th National VBP Round Results Announced: Contracts Worth Over RMB1.3 Billion

Xtalpi Inc. Partners with Amazon Web Services to Accelerate Life Sciences Innovation
CompanyDeals

Xtalpi Inc. Partners with Amazon Web Services to Accelerate Life Sciences Innovation

Jiangxi Jemincare Group Gets NMPA Approval for Prostate Cancer Drug JMX-2006
CompanyDrug

Jiangxi Jemincare Group Gets NMPA Approval for Prostate Cancer Drug JMX-2006

CARsgen Therapeutics Initiates Trial for Universal CAR-T Therapy KJ-C2219 in China
CompanyDrug

CARsgen Therapeutics Initiates Trial for Universal CAR-T Therapy KJ-C2219 in China

We Doctor Holdings Limited Files for IPO on Hong Kong Stock Exchange
CompanyDeals

We Doctor Holdings Limited Files for IPO on Hong Kong Stock Exchange

Shinva Medical Instrument to Acquire Stake in Wuhan Zhongzhi Biotechnologies for IVD Expansion
CompanyDeals

Shinva Medical Instrument to Acquire Stake in Wuhan Zhongzhi Biotechnologies for IVD Expansion

Hinova Pharmaceuticals' HP568 Earns FDA Clinical Trial Approval for ER+/HER2- Breast Cancer
CompanyDrug

Hinova Pharmaceuticals’ HP568 Earns FDA Clinical Trial Approval for ER+/HER2- Breast Cancer

CanSino Biologics' Menhycia Receives Market Approval in Indonesia
CompanyDrug

CanSino Biologics’ Menhycia Receives Market Approval in Indonesia